Schraen-Maschke S - Search Results

1

Extracellular vesicles: Major actors of heterogeneity in tau spreading among human tauopathies.

Leroux E, Perbet R, Caillierez R, Richetin K, Lieger S, Espourteille J, Bouillet T, Bégard S, Danis C, Loyens A, Toni N, Déglon N, Deramecourt V, Schraen-Maschke S, Buée L, Colin M. Leroux E, et al. Mol Ther. 2022 Feb 2;30(2):782-797. doi: 10.1016/j.ymthe.2021.09.020. Epub 2021 Sep 24. Mol Ther. 2022. PMID: 34563677 Free PMC article.

2

Biochemistry of Tau in Alzheimer's disease and related neurological disorders.

Sergeant N, Bretteville A, Hamdane M, Caillet-Boudin ML, Grognet P, Bombois S, Blum D, Delacourte A, Pasquier F, Vanmechelen E, Schraen-Maschke S, Buée L. Sergeant N, et al. Expert Rev Proteomics. 2008 Apr;5(2):207-24. doi: 10.1586/14789450.5.2.207. Expert Rev Proteomics. 2008. PMID: 18466052 Review.

3

Tau as a biomarker of neurodegenerative diseases.

Schraen-Maschke S, Sergeant N, Dhaenens CM, Bombois S, Deramecourt V, Caillet-Boudin ML, Pasquier F, Maurage CA, Sablonnière B, Vanmechelen E, Buée L. Schraen-Maschke S, et al. Biomark Med. 2008 Aug;2(4):363-84. doi: 10.2217/17520363.2.4.363. Biomark Med. 2008. PMID: 20477391 Free PMC article.

4

[Molecular actors in Alzheimer's disease: which diagnostic and therapeutic consequences?].

Buée L, Blum D, Bombois S, Buée-Scherrer V, Caillet-Boudin ML, Colin M, Deramecourt V, Dhaenens CM, Galas MC, Hamdane M, Humez S, Maurage CA, Pasquier F, Sablonnière B, Schraen-Maschke S, Sergeant N. Buée L, et al. Therapie. 2010 Sep-Oct;65(5):401-7. doi: 10.2515/therapie/2010054. Epub 2010 Dec 13. Therapie. 2010. PMID: 21144474 French.

5

Beneficial effects of exercise in a transgenic mouse model of Alzheimer's disease-like Tau pathology.

Belarbi K, Burnouf S, Fernandez-Gomez FJ, Laurent C, Lestavel S, Figeac M, Sultan A, Troquier L, Leboucher A, Caillierez R, Grosjean ME, Demeyer D, Obriot H, Brion I, Barbot B, Galas MC, Staels B, Humez S, Sergeant N, Schraen-Maschke S, Muhr-Tailleux A, Hamdane M, Buée L, Blum D. Belarbi K, et al. Neurobiol Dis. 2011 Aug;43(2):486-94. doi: 10.1016/j.nbd.2011.04.022. Epub 2011 May 4. Neurobiol Dis. 2011. PMID: 21569847

6

Targeting phospho-Ser422 by active Tau Immunotherapy in the THYTau22 mouse model: a suitable therapeutic approach.

Troquier L, Caillierez R, Burnouf S, Fernandez-Gomez FJ, Grosjean ME, Zommer N, Sergeant N, Schraen-Maschke S, Blum D, Buee L. Troquier L, et al. Curr Alzheimer Res. 2012 May;9(4):397-405. doi: 10.2174/156720512800492503. Curr Alzheimer Res. 2012. PMID: 22272619 Free PMC article.

7

A new decision tree combining Abeta 1-42 and p-Tau levels in Alzheimer's diagnosis.

Bombois S, Duhamel A, Salleron J, Deramecourt V, Mackowiak MA, Deken V, Sergeant N, Pasquier F, Buée L, Sablonniére B, Schraen-Maschke S. Bombois S, et al. Curr Alzheimer Res. 2013 May 1;10(4):357-64. doi: 10.2174/1567205011310040002. Curr Alzheimer Res. 2013. PMID: 23061918

8

Association of plasma β-amyloid with MRI markers of structural brain aging the 3-City Dijon study.

Kaffashian S, Tzourio C, Soumaré A, Dufouil C, Mazoyer B, Schraen-Maschke S, Buée L, Debette S. Kaffashian S, et al. Neurobiol Aging. 2015 Oct;36(10):2663-70. doi: 10.1016/j.neurobiolaging.2015.03.016. Epub 2015 Jul 2. Neurobiol Aging. 2015. PMID: 26242707 Free article.

9

Tau Protein Quantification in Human Cerebrospinal Fluid by Targeted Mass Spectrometry at High Sequence Coverage Provides Insights into Its Primary Structure Heterogeneity.

Barthélemy NR, Fenaille F, Hirtz C, Sergeant N, Schraen-Maschke S, Vialaret J, Buée L, Gabelle A, Junot C, Lehmann S, Becher F. Barthélemy NR, et al. J Proteome Res. 2016 Feb 5;15(2):667-76. doi: 10.1021/acs.jproteome.5b01001. Epub 2016 Jan 19. J Proteome Res. 2016. PMID: 26742856

10

Differential Mass Spectrometry Profiles of Tau Protein in the Cerebrospinal Fluid of Patients with Alzheimer's Disease, Progressive Supranuclear Palsy, and Dementia with Lewy Bodies.

Barthélemy NR, Gabelle A, Hirtz C, Fenaille F, Sergeant N, Schraen-Maschke S, Vialaret J, Buée L, Junot C, Becher F, Lehmann S. Barthélemy NR, et al. J Alzheimers Dis. 2016;51(4):1033-43. doi: 10.3233/JAD-150962. J Alzheimers Dis. 2016. PMID: 26923020

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

57 results

Search Page